Dr. Rami Alhassan, MD

  • Orlando, FL
  • Cytopathology physician
NPI1598179236PAC ID1759702723
Medicare services, 2024
2,598
Medicare patients, 2024
813
Publications
2
MIPS score, 2024
98
Hospital affiliations
1
Practice address
601 E Rollins St, Orlando, FL 32803
Practice phone
Call (407) 303-1976
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

AdventHealth Orlando

Hospital · Orlando, Florida

Find Dr. Alhassan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Rami Alhassan is a cytopathology physician in Orlando, Florida

Dr. Alhassan practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Alhassan's NPI, 1598179236, was assigned on June 19, 2014. Dr. Alhassan graduated from Zucker School of Medicine in 2018. Dr. Alhassan holds Florida license ME145567.

NPI and contact details
Medicare PAC ID
1759702723
NPI enumeration date
June 19, 2014
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(407) 303-1976
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
39
Medical school graduation
2018

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Rami Alhassan practices at AdventHealth Orlando in Orlando, Florida

Dr. Alhassan's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Source: Dmand AI Affiliation Data

Dr. Rami Alhassan is affiliated with 1 site of care and 1 medical group

Dr. Alhassan's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is Central Florida Pathology Associates (CFPA).

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Rami Alhassan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alhassan practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
AdventHealth OrlandoAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Alhassan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across AdventHealth and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Rami Alhassan is one of 20 cytopathology physicians in Florida

Cytopathology is Dr. Alhassan's primary specialty in the NPI Registry, under taxonomy code 207ZC0500X. Dr. Alhassan is board certified in cytopathology by the American Board of Pathology. Dmand AI has Dr. Alhassan's licenses on file in 3 states: Florida, Utah and Pennsylvania.

Specialties and state licenses

  • Cytopathology, FloridaPrimaryLicense ME145567 · 2020 to 2026 · taxonomy 207ZC0500X
  • Utah licenseLicense 11275367-1205 · 2019 to 2022
  • Pennsylvania license2018

Cytopathology physicians near Dr. Alhassan

Counts of cytopathology physicians with a Dmand AI profile, by place and practice. Each opens the list.

20cytopathology physicians in Florida
2cytopathology physicians in Orlando

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Rami Alhassan billed Medicare for 2,598 services in 2024

CMS data shows 2,598 Medicare services from Dr. Alhassan across 15 procedure codes in 2024, for 813 Medicare patients. Medicare paid $80,635 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20242,598
Medicare patients813
Paid by Medicare$80,635
Procedure codes15

Dr. Alhassan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 3,5172024: 2,58027%
Other services
2023: 142024: 1829%

Dr. Alhassan compared with the Florida median for cytopathology physicians, 2024

  • Dr. Alhassan
  • Florida median
Medicare services
2,598vs 1,58664% above
Medicare patients
813vs 58838% above

Medians across 17 cytopathology physicians in Florida with Dmand AI profiles that report each measure.

Dr. Alhassan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Alhassan

Need commercial claims for Dr. Alhassan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alhassan and other cytopathology physicians in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Rami Alhassan treated 813 Medicare patients in 2024, average age 73

CMS counts 813 Medicare patients who saw Dr. Alhassan in 2024. The largest group is 65 to 74, with 399 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alhassan's median patient age at 65, with 60% women.

Medicare patients, 2024813
Average age73
Average risk score1.71
Also on Medicaid11%

Dr. Alhassan's Medicare patients by age, 2024

Dr. Alhassan's Medicare patients by sex, 2024

  • Women41751%
  • Men39649%

Chronic conditions among Dr. Alhassan's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis50%
  4. Ischemic heart disease45%
  5. Diabetes40%
  6. Chronic kidney disease38%
  7. Cancer37%
  8. Anxiety31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Alhassan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women60%
  • Men40%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Rami Alhassan scored 98 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Alhassan for performance year 2024, reported as part of a group. Dr. Alhassan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Alhassan's MIPS scores, performance year 2024

  • 98of 100Final score
  • 99.5of 100Quality
  • 40of 100Improvement Activities
  • 84of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find cytopathology physicians like Dr. Alhassan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Rami Alhassan has 2 publications on record

Dmand AI links 2 papers to Dr. Alhassan in 2022. Dr. Alhassan's most frequent co-authors are Kristin Mary Digregorio, DO, Vladimir Kostadinov Neychev, MD, PhD and Jeannine A. Villella, DO.

Papers2

Dr. Alhassan's most frequent co-authors

Recent publications by Dr. Alhassan

See all 2 publications and co-authors

See who Dr. Alhassan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Alhassan works with, so you can find a warm path to the right cytopathology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Rami Alhassan received $140 in industry payments from 2023 to 2025

CMS Open Payments shows 3 general payments to Dr. Alhassan from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $87.

General payments to Dr. Alhassan by program year, 2023 to 2025

Companies that paid Dr. Alhassan the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Alhassan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Rami Alhassan graduated from Zucker School of Medicine

Dr. Alhassan graduated from Zucker School of Medicine in 2018.

  1. Medical schoolZucker School of Medicine
  2. Board certified in cytopathologyAmerican Board of Pathology
  3. Board certified in pathology - anatomic/pathology - clinicalAmerican Board of Pathology

Source: Dmand AI Professional Profile Data

Dr. Rami Alhassan accepts plans from 2 insurance carriers

Dr. Alhassan is in network with 2 carriers, including Cigna and CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Cigna
  • CMS Medicare

Plan types Dr. Alhassan accepts, by number of carriers

  1. Medicare1
  2. PPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Rami Alhassan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Rami Alhassan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Rami Alhassan's NPI number?

Dr. Rami Alhassan's NPI number is 1598179236. It was assigned on June 19, 2014, and it is active in the NPI Registry.

What kind of doctor is Dr. Rami Alhassan?

Dr. Rami Alhassan is a cytopathology physician in Orlando, Florida. The primary specialty in the NPI Registry is Cytopathology Physician (taxonomy code 207ZC0500X).

Where does Dr. Rami Alhassan practice?

Dr. Alhassan practices at 601 E Rollins St, Orlando, FL 32803. Dr. Alhassan's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

What is Dr. Rami Alhassan's office phone number?

The practice phone on file for Dr. Alhassan is (407) 303-1976.

What is Dr. Rami Alhassan's medical license number?

Dr. Alhassan holds Florida license ME145567, one of the licenses on file in 3 states.

Which states has Dr. Rami Alhassan been licensed in?

Dmand AI has state licenses on file for Dr. Alhassan in Florida (2020 to 2026), Utah (2019 to 2022) and Pennsylvania (2018).

Which hospitals is Dr. Rami Alhassan affiliated with?

Dr. Alhassan practices at AdventHealth Orlando in Orlando, Florida.

What medical group is Dr. Rami Alhassan part of?

Dr. Alhassan is linked to Central Florida Pathology Associates (CFPA).

Does Dr. Rami Alhassan accept Medicare?

Yes. CMS data shows Dr. Alhassan billed Medicare for 2,598 services in 2024, and Dr. Alhassan accepts Medicare assignment.

What is Dr. Rami Alhassan's MIPS score?

Dr. Alhassan's MIPS final score for performance year 2024 is 98 out of 100, reported as part of a group.

Show 9 more questionsShow fewer questions

How many Medicare patients does Dr. Rami Alhassan see?

CMS counts 813 Medicare patients who saw Dr. Alhassan in 2024, with an average age of 73.

Is Dr. Rami Alhassan board certified?

Yes. Dr. Alhassan is board certified in cytopathology by the American Board of Pathology.

What services does Dr. Rami Alhassan bill to Medicare?

In 2024, Dr. Alhassan's most billed Medicare services were lab and pathology test (88305), lab and pathology test (88312) and lab and pathology test (88341).

Where did Dr. Rami Alhassan go to medical school?

Dr. Alhassan graduated from Zucker School of Medicine in 2018.

Has Dr. Rami Alhassan received payments from drug or device companies?

CMS Open Payments shows $140 in general payments to Dr. Alhassan from 2 companies from 2023 to 2025. The largest total came from Roche Diagnostics Corporation.

How long has Dr. Rami Alhassan been practicing?

Dr. Alhassan graduated from medical school in 2018, 8 years ago.

Does Dr. Rami Alhassan do research?

Dmand AI links 2 publications to Dr. Alhassan.

Who does Dr. Rami Alhassan publish with?

Dr. Alhassan's most frequent co-authors are Kristin Mary Digregorio, DO (1 shared paper), Vladimir Kostadinov Neychev, MD, PhD (1 shared paper) and Jeannine A. Villella, DO (1 shared paper).

What insurance does Dr. Rami Alhassan accept?

Dr. Alhassan is in network with 2 carriers, including Cigna and CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to cytopathology practices?

See cytopathology physicians in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)